id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-292650-i95upz10	Marafini, Irene	LOW FREQUENCY OF COVID-19 IN INFLAMMATORY BOWEL DISEASES	2020-06-13		.txt	text/plain	1053	56	53	The risk of infection or death due to Covid-19 in patients with inflammatory bowel diseases (IBD) is unknown at this stage. We here examined the frequency of symptoms/signs suggestive of Covid-19 in IBD patients and assessed the risk of SARS-CoV-2 infection in IBD. Cumulative incidence of SARS-CoV-2 infection in IBD was calculated dividing the positive cases by the overall population of IBD patients enrolled for the study. Although, we need more robust epidemiological data to draw a conclusion regarding the incidence rate of Covid-19 in IBD, our findings suggest that IBD patients are not at increased risk of Covid-19 as compared with the general population. It is likely that the incidence of SARS-CoV-2 infection in our IBD population is underestimated as the majority of the patients did not underwent rhino-pharyngeal swab. published recently by Norsa and colleagues, who reported no case of SARS-CoV-2 infection in a cohort of IBD patients living in a high-risk area of Northern Italy (7).	./cache/cord-292650-i95upz10.txt	./txt/cord-292650-i95upz10.txt